https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01008/full
Frontiers | Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins
Natural killer (NK) cells are an attractive cell-type for adoptive immunotherapy, but challenges in preparation of therapeutic primary NK cells restrict pati...
nk 92